Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib and Effect on the QT/QTc Interval in Healthy Participants.
Journal: Clinical and translational science
Published: November 12, 2025
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.
Journal: Neurology open access
Published: July 08, 2025
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study.
Journal: The Lancet. Neurology
Published: August 20, 2024
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Journal: Multiple sclerosis and related disorders
Published: September 06, 2021
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 04, 2021
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus.
Journal: Science translational medicine
Published: November 23, 2020
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 23, 2020
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Journal: Lancet (London, England)
Published: April 17, 2019
Neuromyelitis optica spectrum disorder: Patient experience and quality of life.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 11, 2019
Retinal measurements predict 10-year disability in multiple sclerosis.
Journal: Annals of clinical and translational neurology
Published: July 24, 2018
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.
Journal: Therapeutic advances in neurological disorders
Published: November 02, 2017
Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community.
Journal: Multiple sclerosis and related disorders
Published: February 02, 2017
Last Updated: 09/26/2026